Loading...

Burl Don

TitleHs Clin Prof
InstitutionUniversity of California Davis
DepartmentNephrology
Phone916-734-3774
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Southern California, Los AngelesM.D.6/80
    UC San Francisco, San FranciscoNephrology6/87

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Paracuelles VC, Hodge ML, Craig M, Don BR, Wilson MD, Ingram K, Soohoo L. Simplifying Dialysis Dose Measurement in the Hospital Setting: Kt/V Ionic Dialysance (ID) versus Kt/V(urea). Nephrol Nurs J. 2015 Mar-Apr; 42(2):187-9. PMID: 26207280.
      View in: PubMed
    2. Molfino A, Don BR, Kaysen GA. Comparison of bioimpedance and dual-energy x-ray absorptiometry for measurement of fat mass in hemodialysis patients. Nephron Clin Pract. 2012; 122(3-4):127-33. PMID: 23689544; PMCID: PMC4353643.
    3. Park-Sigal J, Don BR, Porzig A, Recker R, Griswold V, Sebastian A, Duh QY, Portale AA, Shoback D, Schambelan M. Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone. J Bone Miner Res. 2013 Mar; 28(3):700-8. PMID: 23074096.
      View in: PubMed
    4. Don BR, Kim K, Li J, Dwyer T, Alexander F, Kaysen GA. The effect of etanercept on suppression of the systemic inflammatory response in chronic hemodialysis patients. Clin Nephrol. 2010 Jun; 73(6):431-8. PMID: 20497755.
      View in: PubMed
    5. Thornton BD, Hoffman HM, Bhat A, Don BR. Successful treatment of renal amyloidosis due to familial cold autoinflammatory syndrome using an interleukin 1 receptor antagonist. Am J Kidney Dis. 2007 Mar; 49(3):477-81. PMID: 17336710.
      View in: PubMed
    6. Don BR, Spin G, Nestorov I, Hutmacher M, Rose A, Kaysen GA. The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis. J Pharm Pharmacol. 2005 Nov; 57(11):1407-13. PMID: 16259772.
      View in: PubMed
    7. Tsai JJ, Yeun JY, Kumar VA, Don BR. Comparison and interpretation of urinalysis performed by a nephrologist versus a hospital-based clinical laboratory. Am J Kidney Dis. 2005 Nov; 46(5):820-9. PMID: 16253721.
      View in: PubMed
    8. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004 Nov-Dec; 17(6):432-7. PMID: 15660573.
      View in: PubMed
    9. Don BR, Chin AI. A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies. Clin Nephrol. 2003 Jun; 59(6):463-70. PMID: 12834180.
      View in: PubMed
    10. Kaysen GA, Don BR. Factors that affect albumin concentration in dialysis patients and their relationship to vascular disease. Kidney Int Suppl. 2003 May; (84):S94-7. PMID: 12694319.
      View in: PubMed
    11. Gandhi S, Kalantar-Zadeh K, Don BR. Thin-glomerular-basement-membrane nephropathy: is it a benign cause of isolated hematuria? South Med J. 2002 Jul; 95(7):768-71. PMID: 12144088.
      View in: PubMed
    12. Don BR, Rosales LM, Levine NW, Mitch W, Kaysen GA. Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int. 2001 Mar; 59(3):1114-20. PMID: 11231368.
      View in: PubMed
    13. Kalantar-Zadeh K, Don BR, Rodriguez RA, Humphreys MH. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis. 2001 Mar; 37(3):564-72. PMID: 11228181.
      View in: PubMed
    14. Don BR. The effect of trimethoprim on potassium and uric acid metabolism in normal human subjects. Clin Nephrol. 2001 Jan; 55(1):45-52. PMID: 11200867.
      View in: PubMed
    15. Don BR, Kaysen GA. Assessment of inflammation and nutrition in patients with end-stage renal disease. J Nephrol. 2000 Jul-Aug; 13(4):249-59. PMID: 10946803.
      View in: PubMed
    16. Giacchetti G, Sechi LA, Griffin CA, Don BR, Mantero F, Schambelan M. The tissue renin-angiotensin system in rats with fructose-induced hypertension: overexpression of type 1 angiotensin II receptor in adipose tissue. J Hypertens. 2000 Jun; 18(6):695-702. PMID: 10872553.
      View in: PubMed
    17. al-Uzri A, Holliday MA, Gambertoglio JG, Schambelan M, Kogan BA, Don BR. An accurate practical method for estimating GFR in clinical studies using a constant subcutaneous infusion. Kidney Int. 1992 Jun; 41(6):1701-6. PMID: 1501425.
      View in: PubMed
    18. Wada L, Don BR, Schambelan M. Hormonal mediators of amino acid-induced glomerular hyperfiltration in humans. Am J Physiol. 1991 Jun; 260(6 Pt 2):F787-92. PMID: 1647685.
      View in: PubMed
    19. Don BR, Kaysen GA, Hutchison FN, Schambelan M. The effect of angiotensin-converting enzyme inhibition and dietary protein restriction in the treatment of proteinuria. Am J Kidney Dis. 1991 Jan; 17(1):10-7. PMID: 1986564.
      View in: PubMed
    20. Kaysen GA, Don B, Schambelan M. Proteinuria, albumin synthesis and hyperlipidaemia in the nephrotic syndrome. Nephrol Dial Transplant. 1991; 6(2):141-9. PMID: 1857529.
      View in: PubMed
    21. Don BR, Schambelan M. Hyperkalemia in acute glomerulonephritis due to transient hyporeninemic hypoaldosteronism. Kidney Int. 1990 Dec; 38(6):1159-63. PMID: 2074657.
      View in: PubMed
    22. Don BR, Sebastian A, Cheitlin M, Christiansen M, Schambelan M. Pseudohyperkalemia caused by fist clenching during phlebotomy. N Engl J Med. 1990 May 03; 322(18):1290-2. PMID: 2325722.
      View in: PubMed
    23. Don BR, Wada L, Kaysen GA, Schambelan M. Effect of dietary protein restriction and angiotensin converting enzyme inhibition on protein metabolism in the nephrotic syndrome. Kidney Int Suppl. 1989 Nov; 27:S163-7. PMID: 2561515.
      View in: PubMed
    24. Don BR, Blake S, Hutchison FN, Kaysen GA, Schambelan M. Dietary protein intake modulates glomerular eicosanoid production in the rat. Am J Physiol. 1989 Apr; 256(4 Pt 2):F711-8. PMID: 2539749.
      View in: PubMed
    25. Schambelan M, Don BR, Kaysen GA, Blake S. Abnormalities of glomerular eicosanoid metabolism in states of glomerular hyperfiltration. Adv Exp Med Biol. 1989; 259:275-304. PMID: 2696356.
      View in: PubMed
    26. Don BR, Schambelan M. Diabetes, dietary protein and glomerular hyperfiltration. West J Med. 1987 Oct; 147(4):449-55. PMID: 2891223; PMCID: PMC1025906.
    27. Hutchison FN, Don BR, Kaysen GA, Blake S, Schambelan M. Dietary protein intake modulates glomerular eicosanoid production in nephrotic rats. Adv Prostaglandin Thromboxane Leukot Res. 1987; 17B:725-8. PMID: 2960179.
      View in: PubMed
    28. Duncan KL, Don BR, Schaeffer LD, Puffer HW, Lee YT, Warner NE. An introductory study of the influence and role of prolactin in mammary tumor growth. Proc West Pharmacol Soc. 1977; 20:195-7. PMID: 578315.
      View in: PubMed